A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

ClinicalTrials.gov ID: NCT05923073

Public ClinicalTrials.gov record NCT05923073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease

Study identification

NCT ID: NCT05923073
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Crohn's Disease

Interventions

Guselkumab Drug

Drug

Eligibility (public fields only)

Age range: 2 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 12, 2024
Primary completion: Oct 26, 2027
Completion: Jul 11, 2028
Last update posted: May 7, 2026

2024 – 2028

United States locations

U.S. sites: 14
U.S. states: 11
U.S. cities: 11

Facility	City	State	ZIP	Site status
Cedars Sinai Medical Center	Los Angeles	California	90048	Recruiting
Connecticut Children's Medical Center	Hartford	Connecticut	06106	Recruiting
Emory University	Atlanta	Georgia	30322	Active, not recruiting
Children's Center for Digestive Health Care	Atlanta	Georgia	30342	Recruiting
Riley Hospital for Children	Indianapolis	Indiana	46202-5225	Recruiting
Boston Childrens Hospital	Boston	Massachusetts	02115	Recruiting
Goryeb Children's Hospital	Morristown	New Jersey	07960	Recruiting
Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center	New York	New York	10021-5663	Recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Recruiting
Columbia University Medical Center	New York	New York	10032	Recruiting
The Children's Medical Center of Dayton	Dayton	Ohio	45404	Recruiting
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Recruiting
Cook Childrens Medical Center	Fort Worth	Texas	76104	Recruiting
University of Vermont Medical Center	Colchester	Vermont	05446	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05923073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05923073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →